Work Here?
Industries
AI & Machine Learning
Biotechnology
Company Size
11-50
Company Stage
Seed
Total Funding
$11.7M
Headquarters
San Francisco, California
Founded
2022
Vevo Therapeutics specializes in drug discovery by using advanced AI models and its Mosaic platform to generate high-resolution in vivo data, which studies drug interactions within living organisms. This method allows them to identify new drug targets and candidates that traditional approaches might miss. They serve pharmaceutical companies and research institutions by providing insights into drug efficacy and gene expression at a single-cell level, making the drug discovery process faster and more cost-effective. The company's goal is to enhance drug development, leading to better treatments for a broader range of patients.
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$11.7M
Above
Industry Average
Funded Over
1 Rounds
Industry standards
Vevo Therapeutics partners with the Parse Biosciences GigaLab to generate 100M cell atlas for AI powered drug discovery.
Vevo Therapeutics, an SF-based biotechnology company, launched today with a $12M seed round led by General Catalyst and Wing Venture Capital using its Mosaic in vivo drug discovery platform and next-generation AI models to uncover better drugs for more patients.
Vevo Therapeutics, a biotechnology company using its Mosaic in vivo drug discovery platform and next generation AI models to uncover better drugs for more patients, launched today with an oversubscribed and upsized $12M seed financing round.
Find jobs on Simplify and start your career today
Industries
AI & Machine Learning
Biotechnology
Company Size
11-50
Company Stage
Seed
Total Funding
$11.7M
Headquarters
San Francisco, California
Founded
2022
Find jobs on Simplify and start your career today